Tuesday, July 7
Perfusion with Alternating Tangential Flow (ATF) Device Cultivates Higher Cell Culture Densities while Retaining High Cell Viabilities
BIOLOGICS MANUFACTURING ASIA 2020 UPSTREAM PROCESSING
Tuesday, July 7
2:20 pm - 2:45 pm
Recorded Video: Watch video

Speaker

  • Seungsun Lee (Speaker) MSAT Upstream part leader, Samsung Biologics

Description

  • Case study on how Samsung Biologics enabled reduced production time using N-1 (3,000L) Perfusion with Alternating Tangential Flow (ATF) Device.
  • Achieving higher cell culture densities (up to 10-fold) whilst retaining high cell viabilities (>98%) at the seed stage (N-1) to enable inoculation of the production bioreactors (15,000L) at higher cell densities and achieve peak cell densities within shorter culture durations.

Add to my calendar

Google

Create your personal schedule through the official app, Whova!

Get Started